Virbac SA risk profile

38 Normal where most of the sector sits

Measured 1 September 2026 from VIRP's filed statements. Recomputed nightly.

38 (Normal), driven by Competitive position at 44, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation34NormalStableOne-year price volatility — 25.8%
Operating pressure41ElevatedWorseningCosts outgrowing revenue — +0.8 percentage points
Cash conversion41ElevatedWorseningCapital spending against operating cash — 0.51x
Leverage and coverage13ContainedStableCurrent ratio — 1.53x
Competitive position44ElevatedStableRevenue-growth gap against peers — -17.4 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Virbac SA